Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Bridgeport
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Bridgeport, CT

Studies commonly pay $75 to $4,500 per completed study

1,445 clinical trials are currently recruiting participants within 30 miles of Bridgeport. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,445studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Bridgeport right now

Top 25 of 1,445 recruiting studies, sorted by proximity — each links to its official registry page

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Advanced Prostate Cancer, Metastatic Prostate Cancer Phase 1 Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (16.0 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05800665)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Yale University — New Haven, Connecticut (16.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Cancer, Period Problem Phase 2 Interventional 60 participants sought
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) — Commack, New York (24.6 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06915116)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (16.0 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection Recurrence Phase 2 Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (21.0 mi) · Sponsor: Acurx Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07513285)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (3.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (16.0 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
PACT Kidney Care — Orange, Connecticut (10.7 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Study of Buntanetap in Participants With PD

Parkinson's Disease (PD), Deep Brain Stimulation Phase 2, Phase 3 Interventional 500 participants sought
New England Institute for Clinical Research (Ki Health Partners) — Stamford, Connecticut (20.3 mi) · Sponsor: Annovis Bio Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284784)

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Solid Tumors, Sarcomas Phase 1 Interventional 180 participants sought
Zai Lab Site 02030 — New Haven, Connecticut (16.0 mi) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07374848)

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

Recurrent Medulloblastoma, Refractory Medulloblastoma Phase 1 Interventional 18 participants sought
Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) — Commack, New York (24.6 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT07698899)

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

EGFR Inhibitor-associated Rash Phase 1, Phase 2 Interventional 32 participants sought
Yale University School of Medicine — New Haven, Connecticut (16.0 mi) · Sponsor: Azitra Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06830863)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — New Haven, Connecticut (16.0 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Bridgeport Hospital — Bridgeport, Connecticut (0.9 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (16.0 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (16.0 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Yale-New Haven Hospital — New Haven, Connecticut (16.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively

Anxiety, Anesthesia Awareness N/A Observational 40 participants sought
Stony Brook University Hospital — Stony Brook, New York (18.6 mi) · Sponsor: Stony Brook University
See eligibility & contact on ClinicalTrials.gov (NCT07559461)

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

Cardiac Arrest N/A Observational 600 participants sought
Yale University — New Haven, Connecticut (16.0 mi) · Sponsor: Boston Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT03261089)

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma, Lymphoma Phase 2 Interventional 152 participants sought
Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities) — Commack, New York (24.6 mi) · Sponsor: Memorial Sloan Kettering Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT05389293)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
Yale University — New Haven, Connecticut (16.0 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Stony Brook, New York (18.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)
Actively enrolling

Studies you may be able to join near Bridgeport

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Bridgeport

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

New England Research Associates, LLC

4641 Main St Ste 3, Bridgeport, CT 06606
(203) 374-9816

Research Center for Clinical Studies, Inc.

★ 5.0
71 East Ave, Norwalk, CT 06851
(203) 838-0070

Clinical Research Consulting LLC

★ 4.0
2080 Bridgeport Ave D, Milford, CT 06460
(203) 386-3115
"Just finishing up a research study with them, they are all very friendly and organized. They are efficient and do a good job of getting you in and ou…"
— Stephen Callahan, 5★

Yale-Griffin Prevention Research Center

130 Division St, Derby, CT 06418
(203) 732-1265

AIHT Education

★ 4.6
480 Lordship Blvd, Stratford, CT 06615
(203) 870-8400
"I had a great experience at AIHT. The instructors were knowledgeable, supportive, and genuinely wanted their students to succeed. The hands-on clinic…"
— Jennifer Arnone, 5★

New England Institute for Clinical Research

★ 5.0
30 Buxton Farm Rd #230, Stamford, CT 06905
(203) 914-1903
"They were my bright spot when I signed up for their cluster headache clinical trial. They actually saved my life, by informing me that I was quickly …"
— Kara Lee, 5★

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Center for Outcomes Research and Evaluation

★ 5.0
195 Church St 5th Floor, New Haven, CT 06510
(203) 497-1239

Yale Center for Clinical Investigation

2 Church St S #401, New Haven, CT 06519
(203) 785-3482

Clinical trials in Bridgeport: what's recruiting

The Bridgeport area currently has 1,445 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Bridgeport, the most active research areas are:

  • Cancer & Oncology12 studies
  • Brain & Mental Health3 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Bridgeport, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Bridgeport

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Bridgeport participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Bridgeport pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Bridgeport?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Bridgeport safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Bridgeport?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Bridgeport.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Bridgeport typically complete one or two studies per year.

Paid clinical trials near Bridgeport

Other metros within reach

New Haven, CT1,174 Danbury, CT1,147 Waterbury, CT1,134 Yonkers, NY4,153 Queens, NY4,161 Bronx, NY4,178 Hartford, CT441 Manhattan, NY4,198

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Bridgeport Bladder Issues Due To Spinal Cord Injury in Bridgeport All conditions

More of CT

New Haven1,174 Danbury1,147 Waterbury1,134 Hartford441 Norwich123

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts